key: cord-0808113-shn6yz6b
authors: Verkhivker, Gennady M.; Agajanian, Steve; Oztas, Deniz Yazar; Gupta, Grace
title: Dynamic Profiling of Binding and Allosteric Propensities of the SARS-CoV-2 Spike Protein with Different Classes of Antibodies: Mutational and Perturbation-Based Scanning Reveal Allosteric Duality of Functionally Adaptable Hotspots
date: 2021-04-14
journal: bioRxiv
DOI: 10.1101/2021.04.13.439743
sha: 07abae6061a738224486577226e2e175ef39a678
doc_id: 808113
cord_uid: shn6yz6b

Structural and biochemical studies of the SARS-CoV-2 spike complexes with highly potent antibodies have revealed multiple conformation-dependent epitopes and a broad range of recognition modes linked to different neutralization responses In this study, we combined atomistic simulations with mutational and perturbation-based scanning approaches to perform in silico profiling of binding and allosteric propensities of the SARS-CoV-2 spike protein residues in complexes with B38, P2B-2F6, EY6A and S304 antibodies representing three different classes. Conformational dynamics analysis revealed that binding-induced modulation of soft modes can elicit the unique protein response to different classes of antibodies. Mutational scanning heatmaps and sensitivity analysis revealed the binding energy hotspots for different classes of antibodies that are consistent with the experimental deep mutagenesis, showing that differences in the binding affinity caused by global circulating variants in spike positions K417, E484 and N501 are relatively moderate and may not fully account for the observed antibody resistance effects. Through functional dynamics analysis and perturbation-response scanning of the SARS-CoV-2 spike protein residues in the unbound form and antibody-bound forms, we examine how antibody binding can modulate allosteric propensities of spike protein residues and determine allosteric hotspots that control signal transmission and global conformational changes. These results show that residues K417, E484, and N501 targeted by circulating mutations correspond to a group of versatile allosteric centers in which small perturbations can modulate collective motions, alter the global allosteric response and elicit binding resistance. We suggest that SARS-CoV-2 S protein may exploit plasticity of specific allosteric hotspots to generate escape mutants that alter response to antibody binding without compromising activity of the spike protein.

The structural and biochemical studies of the SARS-CoV-2 spike (S) glycoproteins and complexes with highly potent antibodies have revealed multiple conformation-dependent epitopes highlighting the link between conformational plasticity of spike proteins and capacity for eliciting specific binding and broad neutralization responses. [1] [2] [3] [4] [5] [6] [7] The potent antibodies often compete and interfere with the mechanism of virus infection that features spontaneous conformational transformations of the SARS-CoV-2 S protein between closed "down" and open "up" forms of the receptor-binding domain (RBD). [7] [8] [9] A general mechanism of population shifts between different functional states of the SARS-CoV-2 S trimers suggested that RBD epitopes can become stochastically exposed to the interactions with the host receptor ACE, leading to the increased population of open S-RBD states priming spike protein for fusion activation. [10] [11] [12] [13] [14] [15] [16] The initial structure of SARS-CoV-RBD complex with a neutralizing antibody 80R showed that the epitope on the S1 RBD overlapped closely with the ACE2-binding site, suggesting that a direct interference mechanism may be responsible for the neutralizing activity. 17 However, several SARS-CoV-specific neutralizing antibodies such as m396, 80R, and F26G19 that block the RBM motif in the open S conformation did not exhibit a strong neutralizing activity against SARS-CoV-2 protein.

A wide spectrum of SARS-CoV-2 antibodies can be divided into several main classes of which class I and class II antibodies target epitopes that target the receptor binding motif (RBM) region of the RBD. [4] [5] [6] Class I is the largest group of structurally characterized monoclonal antibodies against the SARSCoV-2 S-RBD that exhibit a significant overlap with the ACE2 epitope and bind when the RBD is in the open "up" state. Structural and biochemical studies characterized the binding epitopes and molecular mechanisms for a number of class I SARS-CoV-2 antibodies including 4 REGN10933, 18 B38, 19 CB6, 20 CC12.3, 21 C105, 7 and BD-236. 22 The REGN-COV2 cocktail of REG10933 (RBM-specific class I) and REGN10987 (RBD core-specific) demonstrated significant potential in preventing mutational escape. 23 SARS-CoV-2 antibodies B38 and H4

can bind simultaneously to different epitopes on RBD such that both antibodies together confer a stronger neutralizing effect than either antibody individually. Structural analysis showed that B38 binding epitope spans 36 residues on the RBD of which 15 are conserved between SARS-Cov-2 and SARS-CoV and reside within the ACE2 binding interface. 19 Some of the known escaping mutations are within the epitopes for the neutralizing antibody B38 (K458R, D405V). 24 A new SARS-CoV-2 lineage (501Y.V2) first detected in South Africa is characterized by 21 mutations with 8 lineage-defining mutations in the S protein, including three at important RBD residues (K417N, E484K and N501Y) that have functional significance and often induce significant immune escape. 25, 26 The latest analysis of 17 class I antibody structures confirmed conservation of their conformational epitopes centered on RBD residue K417 which is one of three substitutions in the RBD of the circulating mutation of 501Y.V2

lineage. 27 The antibodies potently neutralized the original lineage, but not the 501Y.V2

pseudovirus revealing a strong dependence on the K417 residue. Class II neutralizing antibodies P2B-2F6 28 , BD-368-2 22 , CV07-270, 29 S2H13 30 , and C121 6 revealed the epitopes that only partially overlap with the ACE2 binding site and, as a result, these antibodies can bind to the S-RBD in both up and down conformation. The potential neutralization mechanisms for class II are more diverse and can include blocking ACE2 from binding and also inducing S1

domain shedding by trapping the RBDs in the up state. Structural comparison of 15 class II antibodies revealed key interactions with residue E484, showing most of these antibodies can be evaded by 501Y.V2 RBD variant that prominently featured E484K mutation. 27 Crystal 5 structure of the S-RBD complex with P2B-2F6 revealed only moderate steric hindrance with the ACE2 binding site and partial interference with viral engagement with ACE2 recepotor. 28 Of 12 RBM contacts, only four residues (N448, G447, Y449, and N450) are conserved in SARS-CoV-2 and SARS-CoV proteins while the only common residues recognized by both P2B-2F6 and ACE2 are G446 and Y449. Despite a small number of key overlapping residues, similar high binding affinities of P2B-2F6 and ACE2 binding suggest that they compete for the RBD interactions. 28 Recently, the crystal structures of several other related antibodies P2C-1F11

and P2C-1A3 bound to the SARS-CoV-2 RBD were determined, showing instructive differences in the angles of antibody approach the RBD and highlighting common and unique binding residues on the S-RBD. 31 Of special interest, one antibody, P2C-1F11 that most closely mimics binding of receptor ACE2, displays the most potent neutralizing activity in vitro and demonstrates the highest binding affinity to RBD. Functional studies showed that F490L, V483A

an L452R mutations can reduce considerably sensitivity to P2B2F6 antibody. 24 Analysis of the molecular determinants and mechanisms of mutational escape showed that SARS-CoV-2 virus rapidly escapes from individual antibodies but doesn't easily escape from the cocktail due to stronger evolutionary constraints on RBD-ACE2 interaction and RBD protein folding. 32 Class III antibodies including CR3022 [33] [34] [35] , and S304 30 bind to the opposite face of the RBD targeting the cryptic epitope that is only accessible when at least two RBDs are in the up state. Structural and surface plasmon resonance studies confirmed that CR3022 binds the RBD of SARS-CoV-2 displaying strong neutralization by allosterically perturbing the interactions between the RBD regions and ACE2 receptor. 34 The neutralization mechanism of SARS-CoV-2 through destabilization of the prefusion S conformation can provide a resistance mechanism to virus escape which can be contrasted with class I antibodies directly 6 competing for the ACE2-binding site and often susceptible to immune evasion. EY6A antibody binds to the same cryptic epitope as CR3022 but exploit a different orientation with respect to the S-RBD corresponding to a 73° rotation around an axis perpendicular to the RBD α3-helix. 36 Interestingly, EY6A binding to the isolated RBD is an order of magnitude better than CR3022 and the unique binding mode allows three EY6A molecules to bind simultaneously around the central axis of the S protein. 36 The antibodies isolated from 10 convalescent COVID-19 patients showed neutralizing activities against authentic SARS-CoV-2, with 4A8 antibody binding to the NTD of the S protein conformation with one RBD in "up" conformation and the other two RBDs in "down" conformation. 37 monoclonal antibodies that bind the RBD was determined. 52 The resulting map shows the antibody footprints forming five major epitopes by cluster analysis, particularly highlighting the role residues E484-F486 that bridge the epitopes and are accessible to antibodies from different approaching angles of attack. Notably, mutations in these positions E484K and F486L

were identified as recurrent mutations identified in the B.1.351 and P.1 lineages. 53, 54 Computational modeling and molecular dynamics ( binding with ACE2 were analyzed in our recent study using coevolution and conformational dynamics. 63 A series of all-atom MD simulations of the SARS-CoV-2 S-RBDS complex with ACE2 in the absence and presence of external force examined the effects of alanine substitutions showing that the hydrophobic end of RBD serves as the main energetic hotspot for ACE2 binding. 64 By using molecular simulations and network modeling we recently presented evidence that the SARS-CoV-2 spike protein can function as an allosteric regulatory engine that fluctuates between dynamically distinct functional states. 65 Coarse-grained normal mode analyses combined with Markov model and computation of transition probabilities characterized the dynamics of the S protein and the effects of mutational variants D614G and N501Y on protein dynamics and energetics. 66 Using time-independent component analysis and protein networks, another computational study identified the hotspot residues that may exhibit long-distance coupling with the RBD opening, showing that some mutations may allosterically affect the stability of the RBD regions. 67 Molecular simulations reveal that N501Y mutation increases ACE2 binding affinity, and may impact the collective dynamics of the ACE2-RBD complex while mutations K417N and E484K reduce the ACE2-binding affinity. 68 In this study, we combined MD simulations with mutational and perturbation-based scanning approaches to perform a comprehensive structural profiling of binding and allosteric propensities of the SARS-CoV-2 S-RBD residues in complexes with three different classes of antibodies. We investigated dynamics, energetics and allosteric potential of the S-RBD protein in complexes with B38, P2B-2F6, EY6A and S304 antibodies. The mutational scanning-based heatmaps reveal the binding energy hotspots for different classes of antibodies indicating that differences in the binding affinity caused by global variants are moderate and are unlikely to fully account for the antibody resistance effects. Through functional dynamics analysis and perturbation-response scanning of the SARS-CoV-2 S-RBD in the unbound form and antibodybound forms, we characterize allosteric propensities of spike protein residues and determine regulatory sites that may function as allosteric hotspots of long-range communications. These results show that residues K417, E484, and N501 targeted by circulating mutations correspond to a group of allosteric centers involved in a coordinated cross-talk to enable antibody-induced modulation of the spike activity. Using different classes of antibodies, we

show that mutational variants constrained by the requirements for preservation of the RBD stability may preferentially target a group of structurally adaptable allosteric centers in which small perturbations can modulate functional motions, alter the global allosteric response and elicit binding resistance. We suggest that SARS-CoV-2 S protein may exploit plasticity of specific allosteric hotspots to generate escape mutants that alter response to antibody binding without compromising activity of the spike protein.

The structures of the SARS-CoV-RBD complexes with three different classes of antibodies were used in our investigation. These structures included the SARS-CoV-2 S-RBD complexes with class I B38 antibody ( Figure 1A ), class II P2B-2F6 antibody ( Figure 1B) , and class III EY6A and S304 antibodies ( Figure 1C ). All structures were obtained from the Protein Data Bank. 69, 70 Hydrogen atoms and missing residues were initially added and assigned according to the WHATIF program web interface. 71, 72 The missing loops in the cryo-EM structures were also reconstructed using template-based loop prediction approaches ModLoop 73 and ArchPRED. 74 The side chain rotamers were refined and optimized by SCWRL4

tool. 75 The protein structures were then optimized using atomic-level energy minimization with a composite physics and knowledge-based force fields using 3Drefine method. 76 

All-atom MD simulations were performed for an N, P, T ensemble in explicit solvent using NAMD 2.13 package 77 with CHARMM36 force field. 78 Long-range non-bonded van der Waals interactions were computed using an atom-based cutoff of 12 Å with switching van der Waals potential beginning at 10 Å. Long-range electrostatic interactions were calculated using the particle mesh Ewald method 79 with a real space cut-off of 1.0 nm and a fourth order (cubic)

interpolation. SHAKE method was used to constrain all bonds associated with hydrogen atoms.

Simulations were run using a leap-frog integrator with a 2 fs integration time step. Energy minimization after addition of solvent and ions was carried out using the steepest descent method for 100,000 steps. All atoms of the complex were first restrained at their crystal structure positions with a force constant of 10 Kcal mol -1 Å -2 . Equilibration was done in steps by gradually increasing the system temperature in steps of 20K starting from 10K until 310 K and at each step 1ns equilibration was done keeping a restraint of 10 Kcal mol-1 Å-2 on the protein Cα atoms.

After the restrains on the protein atoms were removed, the system was equilibrated for additional 10 ns. An NPT production simulation was run on the equilibrated structures for 500 ns keeping the temperature at 310 K and constant pressure (1 atm). In simulations, the Nose-Hoover thermostat 80 and isotropic Martyna-Tobias-Klein barostat 81 were used to maintain the temperature at 310 K and pressure at 1 atm respectively. Principal component analysis (PCA) of MD trajectories using the CARMA package. 82 We also computed the relative solvent accessibility parameter (RSA) that is defined as the ratio of the absolute solvent accessible surface area (SASA) of that residue observed in a given structure and the maximum attainable value of the solvent-exposed surface area for this residue using web server GetArea. 83

Using a protein mechanics-based approach 84 index for each residue is calculated by averaging the distances between the residues over the simulation trajectory using the following expression: 

To compute protein stability changes in the SARS-CoV-2 S-RBD complexes, we conducted mutational sensitivity scanning of protein residues by systematically exploring all possible substitutions. BeAtMuSiC approach was employed that is based on statistical potentials describing the pairwise inter-residue distances, backbone torsion angles and solvent accessibilities, and considers the effect of the mutation on the strength of the interactions at the interface and on the overall stability of the complex. 86 The binding free energy of proteinprotein complex can be expressed as the difference in the folding free energy of the complex and folding free energies of the two protein binding partners:

The change of the binding energy due to a mutation was calculated then as the following:

We leveraged rapid calculations based on statistical potentials to compute the ensembleaveraged binding free energy changes using equilibrium samples from MD trajectories. The binding free energy changes were computed by averaging the results over 1,000 equilibrium samples for each of the studied systems.

Perturbation Response Scanning (PRS) approach 87-89 follows the protocol originally proposed by Bahar and colleagues 90, 91 and was described in detail in our previous studies. 92, 93 In brief, through monitoring the response to forces on the protein residues, the PRS approach can quantify allosteric couplings and determine the protein response in functional movements. In this approach, it 3N × 3N Hessian matrix whose elements represent second derivatives of the potential at the local minimum connect the perturbation forces to the residue displacements. The perturbations of all residues and its average is denoted as 〈(∆ ) 2 〉 . The sensor profile measures the ability of residue j to serve as a receiver of dynamic changes in the system.

Using MD simulations, we examined how SARS-CoV-2 spike protein can exploit plasticity of the RBD regions to modulate specific dynamic responses to antibody binding. MD simulations of the RBD-antibody complexes revealed functionally important modulation of the conformational dynamics and appreciable redistribution of the S-RBD stability profiles. The RBD core remained stable during while mobility of some flexible regions could be significant altered ( Figure 2 ).

Instructively, the largest binding-induced dynamic changes were seen in the S-RBD complex with B38, exemplified by significant stabilization of flexible residues around K417 site ( Figure   2A ). An appreciable modulation of the S-RBD mobility was also seen in the loop region (residues 457-480) and RBM ridge (residues 490-505) that display moderate thermal fluctuations in the complex (Figure 2A ). The strategic functional positions K417 and N501 are stabilized in the RBD-B38 complex, but residues around E484 position are noticeably more flexible ( Figure   2A ). The distribution of the distinct inter-molecular residue pairs revealed antibody contacts with a wide range of residues including D420, K417, Y421, K458, G476, D427, F486, Y489, Q498, N501, Y505 of the SARS-CoV-2 RBD (Supporting Information, Figure S1A ). In Figure S1A ). A similar dynamic pattern was detected in the S-RBD complex with class II P2B-2F6 antibody that binds to the RBM region using a different recognition angle with the binding epitope centered on G446/Y449 and E484/F490 residues ( Figure 2B ). These key epitope residues showed modest thermal fluctuations and were stabilized in the complex, but the overall mobility of the S-RBD was greater as compared the RBD-B38 complex. The inter-residue interaction pairs are formed with V445, G446, and Y449 site (Supporting Information, Figure S2B ). In particular Y449 residue is involved in numerous contacts with Y27, V104, G32, S31, Y33, and G102 of heavy chain of B38. Of special notice also a number of the inter-residue pair contacts made by E484, F486, and F490 residues (Supporting Information, Figure S1B ). E484 forms hydrogen bonds with N33 and Y34 of the P2B-2F6 light chain and with R112 of the P2B-2F6 heavy chain. for binding of EY6A and S304 antibodies where such mutations may be more readily accommodated. 36 Notably, this class of antibodies may not only promote further stabilization of the RBD core but could also modulate mobility of the RBM region. As a result, even though EY6A binding does not impose steric hindrance on interactions with ACE2 ( Figure 1F ), by differentially modulating stability of the RBM residues EY6A may allosterically induce a weak inhibitory effect on binding with the host receptor. 36 A similar distribution of the inter-residue pairs can be mediated by EY6A and S304 antibodies.

For EY6A, the large numbers of contacts are established by G381, V382, S383, P384, T385, and K386 residues that form the core of the binding epitope (Supporting Information, Figure   S1C ). A less dense network of contacts is maintained by S304 antibody in the complex, featuring C379, G381, V382, and S383 RBD residues forming contacts with distinct positions on both heavy and light chains (Supporting Information, Figure S1D ).

We compared profiles for the unbound SARS-CoV-2 S-RBD form with the respective distributions in the antibody-bound states to determine how binding modulates conformational mobility of the S-RBD residues. Using the ensemble-based distance fluctuations analysis of the unbound SARS-CoV-2 S-RBD we first identified intrinsically structurally stable regions and characterize dynamic signatures of the binding epitopes (Supporting Information, Figure S2 ).

The analysis highlighted several important "islands" of structural stability that are primarily Figure S2 ). The large binding epitope for B38 featured stable segments (residues 403-421, 453-460) as well as more flexible region (residues 473-480) (Supporting Information, Figure S2A ). Interestingly, the binding epitopes for EY6A and S304 antibodies targeting the conserved RBD core included moderately stable RBD residues, and only residues F377 and F429 were aligned with the local maxima of the profile (Supporting Information, Figure   S2C ,D).

The distance fluctuation stability profiles for the S-RBD complexes with antibodies revealed how binding can induce changes in the distribution of rigid and flexible regions (Figure 3 ). In the complex with B38 antibody, one could notice a significant stabilization of the RBM residues involved in the binding interactions ( Figure 3A ). In particular, functional sites K417 and N501

become considerably more stable while E484 residue retained relatively high mobility present in the unbound RBD form. Despite the overlap of the binding epitopes for B38 and P2B-2F6

antibodies that target the RBM region, the stability profiles for these complexes featured several specific signatures ( Figure 3B ). The distance fluctuation profile for the P2B-2F6 complex pointed to a moderate mobility of K417 and N501 sites, while revealing a markedly increased stabilization of highly mobile region centered on E484 in the RBM region ( Figure 3B ) We specifically mapped stable spike residues that form local modular clusters in the structures of the SARS-CoV-2 S-RBD complexes with antibodies ( Figure 4 ). These structurally stable residues in the complex with class I B38 antibody connect the peripheral spike regions through the RBD core to the binding interface ( Figure 4A) . Moreover, the functional sites K417, N501 and E484 appeared to form a network of intermolecular bridges that link the stable RBD core with the antibody. Interestingly, although P2B-2F6 interactions with S-RBD are centered on E484 site, these interactions are fairly isolated and separated from the dense clusters of stable residues of the RBD core ( Figure 4B ). In this complex, N501 residue provided the link between stable RBD clusters and the inter-molecular interface. For class III antibody EY6A, the binding interface is linked with the stable RBD core, illustrating the observed rigidification of these regions ( Figure 4C ). Functional centers of K417 and N501 are directly linked to these stable clusters suggesting that these positions could sense the antibody-induced signal and alter their dynamics as a part of protein response.

To enhance this dynamics-based analysis, we also employed the conformational ensemble to compute the relative solvent accessibility (RSA) ratio in the SARS-CoV-2 RBD complexes.

This parameter was obtained by averaging the SASA computations over the simulation trajectories ( Figure 5 ). Of particular interest were the average RSA values for functional sites K417, E484, and N501 that are residues targeted by circulating mutations. Interestingly, B38 and P2B-2F6 antibodies yielded a different pattern of RSA for these sites. For B38-RBD complex, we observed that K417 and N501 positions are buried featuring RSA < 10% ( Figure 5A ), while E484 position is largely solvent-exposed. In the complex with P2B-2F6, both N501 and especially E484 become > 80% buried (RSA< 20%) while K417 site remained partly exposed to solvent ( Figure 5B ). This class of antibodies revealed key interactions with residue E484, showing most of these antibodies can be evaded by 501Y.V2 RBD variant that prominently featured E484K mutation. 27 Because EY6A and S304 antibodies target the cryptic site located away from the RBD regions, the functional sites K417 and E484 were mostly exposed with N501 only moderately buried ( Figure 5C,D) . It should be pointed out that surrounding residues in this RBM ridge (T500, V503, G504, and T505) are completely exposed featuring RSA values between 65% and 80% . Hence, different classes of antibodies may induce distinct patterns of solvent accessibility in the functional positions subjected to circulating mutations.

We also characterized collective motions for the SARS-CoV-2 S-RBD complexes averaged over low frequency modes using principal component analysis (PCA) of the MD trajectories ( Figure 6 ). It is worth noting that the local minima along these profiles are typically aligned with the immobilized in global motions hinge centers, while the maxima correspond to the moving regions undergoing concerted movements leading to global changes in structure. 95 The low-frequency 'soft modes' are characterized by their cooperativity, functional significance and robustness whereby there is a strong relationship between allosterically-driven conformational changes and the 'soft' modes of motions intrinsically accessible to folded structures. 95.96 It is well established that allosteric responses in proteins can be efficiently triggered when external stimuli (such as mutations, ligand or antibody binding) can exploit the intrinsic protein propensities for energetically favorable movement along the slow modes. 96 Hence, targeting these regions by antibodies could potentially change the spectrum of slow modes and induce specific functional motions characteristic for different antibody classes.

Indeed, for the class I B38 antibody whose binding mode is centered on K417 region, the global mobility distribution was markedly altered, showing how binding can shifty the location of major hinge sites ( Figure 6A ). We noted that B38 binding did not affect hinge residues in the RBD core as residues Y351, F374, and G404 were aligned with the local minima of the profile.

At the same time, the slow mode profile for the complex revealed local minima near K417, E484 and N501 residues ( Figure 6A) . Moreover, the entire moving region of the unbound from forms aligned with the moving regions in collective dynamics ( Figure 6C,D) . Moreover, binding of these may preserve or amplify mobility of the key regions surrounding E484 and N501 residues. This may allow for simultaneous binding of ACE2 albeit prone to the experimentally detected faster dynamic exchange and dissociation. 36 According to the experiments, attachment of preincubated RBD and EY6A to immobilized ACE2 indicated that the off-rate from ACE2 was increased by the presence of EY6A, suggesting a crosstalk between the binding of ACE2 and EY6A antibodies. 36 Our analysis indicated that EY6A and S304 antibodies could potentially act as modulators of the conformational dynamics without dramatically altering collective motions and allosteric protein response but rather fine-tune dynamic changes at the ACE2-binding site. In this model, antibody binding would strengthen allosteric couplings between ACE2-binding site and cryptic binding site, arguably facilitating a cross-talk between bound ACE2 and antibodies.

To provide further comparison between the computational and experimental data, we performed mutational sensitivity analysis and constructed mutational heatmaps for SARS-CoV-2 S-RBD binding (Figure 7) . The binding epitope of the class I antibody B38 has a considerable overlap with the ACE2 binding site (Figure 1 ). In fact, 21 residues of the SARS-CoV-2 S-RBD are shared between epitope residues bound by B38 and ACE2. The unique epitope residues that interact with the B38 antibody include D405, E406, T415, G416, D420, Y421, N460, Y473, A475, E484, and G496 ( Figure 7A ). However, only several of these positions (Y421, Y473, A475 residues) corresponded to the binding hotspots ( Figure 7A ). The computed mutational scanning map for the S-RBD binding with B38 pointed to sites K417, Y421, Y453, F456, N487, Q493, and Y505 as the most dominant binding energy hotspots, displaying large destabilization loss in these positions for all substitutions ( Figure 7A ). These results are in good agreement with deep mutational scanning analysis. 19, 42, 45 A considerably smaller binding footprint was found for class II antibody P2B-2F6 binding where major binding hotspots corresponded to the residue cluster surrounding key anchoring position of Y449 ( Figure 7B ). All mutations in this position produced large destabilization changes. A similar mutational scanning signature was observed in positions G447, N450, L452, V483, E484, G485, and F490 ( Figure   7B ). Notably, the most prominent binding energy hotspots corresponded to G447, Y449, E484, and F490 residues. The computed mutational maps reproduced the experimental data by identifying important epitope residues in the cryptic binding site targeted by EY6A and S304

( Figure 7C ). Despite a number of local interaction contacts formed by B38 with functional sites K417, E484

and N501 only K417 featured as an appreciable energetic hotspot. Comparison of predicted

ΔΔGs shows that a number of mutations at K417 site, particularly K417A/G/D/T resulted in a large destabilization effect ( Figure 8A ). In contrast, very minor changes are triggered by modifications of E484 where some mutations such as E484F and E484W may yield moderate stabilization largely due to the enhanced structural stability of this flexible region ( Figure 8B ).

Mutations of N501 residues are generally moderately detrimental to binding with B38 with the exception of N501A and N501Y modifications that caused a more significant loss of binding ( Figure 8C ). We found that circulating mutations K417N ( Figure 8A ) and N501Y ( Figure 8C) could compromise S-RBD binding to the B38 antibody, producing the destabilization effect that can be compounded by simultaneous substitutions in these positions. To compare the free energy changes induced by mutations of the binding epitope we specifically examined the alanine mutation scanning profiles residues in different complexes (Supporting Information, Figure S3 ). By mapping positions of the binding epitopes onto these distributions, we observed high destabilization changes for RBM sites involved in interactions with B38 (Supporting Information, Figure S3A ). Noticeably, binding free energy loss upon alanine mutations of K417 and N501 sites were quite appreciable, confirming that K417 is one of the central epitope residues for B38. A narrower spectrum of the binding epitope residues is evident in the complex with class II P2B-2F6 antibody (Supporting Information, Figure S3B ).

Alanine scanning of only several epitope residues (Y449, L452, E484) produced large destabilization changes. The distribution also highlighted that the RBM residues near Y449 and E484 contribute appreciably to binding affinity by forming two small hotspot clusters (Supporting Information, Figure S3B ) We argue that escape mutations constrained by the requirements for host cell binding and RBD stability may select energetically adaptable sites that compromise antibody recognition through modulation of global motions and allosteric protein responses.

Using the PRS method we probed the allosteric effector and sensor potential of the S-RBD residues in complexes with studied antibodies. In the perturbation-based scanning model, the effector profiles evaluate allosteric propensity of protein residues to efficiently propagate signals over long-range in response to systematically applied external perturbations. Accordingly, the local maxima along the effector profile may serve as an indicator of allosteric hotspots that can influence dynamic changes in other residues and may control signal transmission in the system.

The sensor profile and respective distribution peaks highlight residues that have a strong propensity to sense signals and produce allosteric response through altered dynamics. We compared the PRS effector profile for the unbound S-RBD form and antibody-bound forms ( Figure 9 ). In the complex with B38, several effector peaks corresponding to structurally stable RBD regions (residues 348-352, 400-406) are preserved in the bound form ( Figure 9A ). Due to B38-induced modulation of the effector profile, K417 and N501 positions become aligned with the notable peaks, suggesting that these residues acquire a strong allosteric potential in the complex and correspond to the stable effector hotspots ( Figure 9A ). On the other hand, the effector potential value for the E484 site remained largely unchanged as compared to the unbound form. The PRS sensor profile for the RBD-B38 complex ( Figure 10A ) indicated that none of the functional sites of circulating mutations are mapped onto distribution peaks. As a result, allosteric communication in this complex may be highly dependent mostly on two functional positions K417 and N501. These results support the recent studies suggesting that functional plasticity is central to allosteric regulation where allosteric hotspots may often correspond to structurally adaptable and moderately conserved protein positions. 100 In the S-RBD complex with the class II antibody P2B-2F6, the effector profile was similar to the unbound form, but featured notable changes near E484 and N501 positions ( Figure 9B ). The allosteric effector propensities were markedly increased for E484 residue revealing a strong peak of the distribution, while the effector potential for N501 residue was clearly reduced ( Figure 9B ). Hence, antibody-induced stabilization of Y449 and E484 sites could lead to modulation of its allosteric propensities. As a result, these sites are not only important binding energy hotspots but also acquire significant allosteric potential in the complex. Although the sensor profile for this complex is similar to the one obtained for RBD-B38 complex, we noticed the increased sensor potential for K417 and N501 positions ( Figure 10B ). This suggested that functional sites may be engaged in an allosteric cross-talk of effector and sensor centers, where the binding signal induced by the P2B-2F6 antibody can be transmitted to other RBD regions.

In general, our findings suggested that class II antibody binding exemplified by P2B-2F6 may exhibit strong dependence on Y449 and E484 sites as mutations in these positions could 43 significantly compromise both binding affinity and antibody-induced allosteric signaling. This may be an example where antibody binding recruits structurally adaptable E484 site and significantly alters the pattern of collective motions and communications in the spike protein.

These results are consistent with the experimental evidence according to which E484 and F486 play a central role in this epitope. 32 A different pattern of the effector and sensor centers emerged from the analysis of the S-RBD binding with EY6A and S304 antibodies. For both these III antibodies, the effector profiles were very similar and generally followed the distribution shape of the unbound S-RBD form ( Figure 9C ,D). We noticed a markedly increased effector peaks in the structurally stable regions of the RBD core that are further rigidified by EY6A and S304 binding. We capitalized on the deep mutational screening of CR3022 antibody 45 that features exactly the same footprint as EY6A and S304. The sites of maximum escape for this class III antibodies correspond to C361, V362, K378, V382, S383, F392, T430, I434, A435 residues that are aligned with the effector peaks of the PRS distribution ( Figure 9C,D) . Accordingly, these sites could feature a significant allosteric potential and correspond also to the allosteric control centers in the complexes.

Notably, none of the functional sites of circulating mutations were among effector centers.

Moreover, the effector potential for these residues was relatively low, owing in part to the flexible nature of these regions that are solvent-exposed in complexes with EY6A and S304

( Figure 9C,D) . The PRS sensor profiles for EY6A and S304 bound complexes showed strong peaks for K417, E484, and N501 residues ( Figure 10C,D) . Of notice is the dominant peak in the region centered on E484 and F486 residues. It implies that these positions correspond to the dominant sensor centers that can effectively "absorb" signals sent from the RBD core and execute protein response by altering collective dynamics in flexible regions.

In the PRS approach, the effector and sensor centers may act cooperatively to elicit long-range protein response to antibody binding and propagate allosteric signal through the protein.

Together with the conformational dynamics analysis, our results also showed that class III antibodies may induce rigidification of the RBD core that is accompanied by the increased flexibility of the RBM region, which is a manifestation of dynamics-driven allosteric changes.

This may explain the experimental results according to which even though EY6A cannot prevent ACE2 binding it can substantially increase the dissociation rate between ACE2 and RBD. 36 This may reflect the increased mobility of the RBM residues and localization of key sensor hotspots in the regions interacting with the host receptor. Hence, functional sites K417, E484 and N501 can be involved as either effector or sensor hotspots in the complexes with different classes of antibodies. Hence, structurally and functionally adaptable allosteric centers may be targeted by mutational variants because even small perturbations in these positions would propagate over long-range allowing for modulation of antibody-induced protein response.

Our findings showed that E484 site may be a critical effector hotspot for binding of class II antibodies, while serving as a dominant sensor center in response to binding of class III antibodies. Allosteric duality of this functional site could make it vulnerable to mutations which may alter collective dynamics and potentially be a driver of antibody resistance to the antibody classes I and II . Indeed, mutations in the epitope centered around E484 position (F486, F490) were shown to strongly affect neutralization for different classes of antibodies. 49, 50 Collectively, our findings suggested that SARS-CoV-2 S protein may exploit plasticity of specific allosteric hotspots to generate escape mutants that alter response to antibody binding without compromising activity of the spike protein.

We combined MD simulations with mutational and perturbation-based scanning approaches to perform a comprehensive structural profiling of binding and allosteric propensities of the SARS- This study provides a useful atomistic insight into allosteric regulatory mechanisms of SARS-CoV-2 S proteins, suggesting that circulating mutational variants are likely to emerge in structurally and evolutionary adaptable regulatory switch positions to elicit a differential protein response to the host cell receptor while evading antibody binding.

Phone: 714-516-4586; Fax: 714-532-6048; E-mail: verkhivk@chapman.edu

The authors declare no competing financial interest.

Structural Basis for Potent Neutralization of Betacoronaviruses by Single-Domain Camelid Antibodies

Receptor-binding domain-specific human neutralizing monoclonal antibodies against SARS-CoV and SARS-CoV-2

Fruitful Neutralizing Antibody Pipeline Brings Hope To Defeat SARS-Cov-2

Structural Basis of SARS-CoV-2 and SARS-CoV Antibody Interactions

Structural Analysis of Neutralizing Epitopes of the SARS-CoV-2 Spike to Guide Therapy and Vaccine Design Strategies

SARS-CoV-2 neutralizing antibody structures inform therapeutic strategies

Structures of Human Antibodies Bound to SARS-CoV-2 Spike Reveal Common Epitopes and Recurrent Features of Antibodies

Receptor recognition by the novel coronavirus from Wuhan: An analysis based on decade-long structural studies of SARS coronavirus

Cell entry mechanisms of SARS-CoV-2

Stabilized coronavirus spikes are resistant to conformational changes induced by receptor recognition or proteolysis

Veesler, D. Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein

Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation

Distinct conformational states of SARS-CoV-2 spike protein

Controlling the SARS-CoV-2 spike glycoprotein conformation

Conformational dynamics of SARS-CoV-2 trimeric spike glycoprotein in complex with receptor ACE2 revealed by cryo-EM

Receptor binding and priming of the spike protein of SARS-CoV-2 for membrane fusion

Structural basis of neutralization by a human anti-severe acute respiratory syndrome spike protein antibody, 80R

A noncompeting pair of human neutralizing antibodies block COVID-19 virus binding to its receptor ACE2

A human neutralizing antibody targets the receptor-binding site of SARS-CoV-2

Human neutralizing antibodies elicited by SARS-CoV-2 infection

A human neutralizing antibody targets the receptor-binding site of SARS-CoV-2

Structurally Resolved SARS-CoV-2 Antibody Shows High Efficacy in Severely Infected Hamsters and Provides a Potent Cocktail Pairing Strategy

Antibody cocktail to SARS-CoV-2 spike protein prevents rapid mutational escape seen with individual antibodies

The impact of mutations in SARS-CoV-2 spike on viral infectivity and antigenicity

Emergence and rapid spread of a new severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) lineage with multiple spike mutations in South Africa

Sixteen novel lineages of SARS-CoV-2 in South Africa

SARS-CoV-2 501Y.V2 escapes neutralization by South African COVID-19 donor plasma

Human neutralizing antibodies elicited by SARS-CoV-2 infection

A Therapeutic Non-selfreactive SARS-CoV-2 Antibody Protects from Lung

Mapping Neutralizing and Immunodominant Sites on the SARS-CoV-2 Spike Receptor-Binding Domain by Structure-Guided High-Resolution Serology

Antibody neutralization of SARS-CoV-2 through ACE2 receptor mimicry

Molecular determinants and mechanism for antibody cocktail preventing SARS-CoV-2 escape

A highly conserved cryptic epitope in the receptor binding domains of SARS-CoV-2 and SARS-CoV

Neutralization of SARS-CoV-2 by destruction of the prefusion spike

Structural basis of a shared antibody response to SARS-CoV-2

Structural basis for the neutralization of SARS-CoV-2 by an antibody from a convalescent patient

Structural basis for neutralization of SARS-CoV-2 and SARS-CoV by a potent therapeutic antibody

neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody

Deep Mutational Scanning of SARS-CoV-2 Receptor Binding Domain Reveals Constraints on Folding and ACE2 Binding

Engineering human ACE2 to optimize binding to the spike protein of SARS coronavirus 2

Key residues of the receptor binding motif in the spike protein of SARS-CoV-2 that interact with ACE2 and neutralizing antibodies

Complete Mapping of Mutations to the SARS-CoV-2 Spike Receptor-Binding Domain that Escape Antibody Recognition

Comprehensive mapping of mutations to the SARS-CoV-2 receptor-binding domain that affect recognition by polyclonal human serum antibodies Cell Host Microbe

SARS-CoV-2 escape in vitro from a highly neutralizing COVID-19 convalescent plasma

Landscape analysis of escape variants identifies SARS-CoV-2 spike mutations that attenuate monoclonal and serum antibody neutralization

Prospective mapping of viral mutations that escape antibodies used to treat COVID-19

Antibody cocktail to SARS-CoV-2 spike protein prevents rapid mutational escape seen with individual antibodies

Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants

The antigenic anatomy of SARS-CoV-2 receptor binding domain

Genomic characterization of a novel SARS-CoV-2 lineage from Rio de Janeiro, Brazil

Resurgence of COVID-19 in Manaus, Brazil, despite high seroprevalence

Conformational transition of SARS-CoV-2 spike glycoprotein between its closed and open states

Developing a Fully Glycosylated Full-Length SARS-CoV-2 Spike Protein Model in a Viral Membrane

Beyond Shielding: The Roles of Glycans in the SARS-CoV-2 Spike Protein

Is the Rigidity of SARS-CoV-2 spike receptor-binding motif the hallmark for Its enhanced infectivity? Insights from all-atom simulations

Enhanced receptor binding of SARS-CoV-2 through networks of hydrogen-bonding and hydrophobic interactions

Dynamics of the ACE2-SARS-CoV-2/SARS-CoV spike protein interface reveal unique mechanisms

The SARS-CoV-2 exerts a distinctive strategy for interacting with the ACE2 human receptor

Computational alanine scanning and structural analysis of the SARS-CoV-2 Spike protein/angiotensin-converting enzyme 2 complex

Coevolution, dynamics and allostery conspire in shaping cooperative binding and signal transmission of the SARS-CoV-2 spike protein with human angiotensinconverting enzyme 2

Critical Interactions Between the SARS-CoV-2 Spike Glycoprotein and the Human ACE2 Receptor bioRxiv 2020

Molecular simulations and network modeling reveal an allosteric signaling in the SARS-CoV-2 spike proteins

Modeling conformational state dynamics and its role on infection for SARS-CoV-2 Spike protein variants

Distant Residues Modulate Conformational Opening in SARS-CoV-2 Spike Protein

Impact of South African 501.V2 variant on SARS-CoV-2 spike infectivity and neutralization: A Structure-based computational assessment

The Protein Data Bank

The RCSB protein data bank: integrative view of protein, gene and 3D structural information

Positioning hydrogen atoms by optimizing hydrogenbond networks in protein structures

WIWS: A protein structure bioinformatics web service collection

Automated modeling of loops in protein structures

ArchPRED: A template-based loop structure prediction server

Improved prediction of protein side-chain conformations with SCWRL4

3Drefine: an interactive web server for efficient protein structure refinement

Scalable molecular dynamics with NAMD

Optimization of the additive CHARMM all-atom protein force field targeting improved sampling of the backbone φ, ψ and side-chain χ(1) and χ(2) dihedral angles

A Stochastic Algorithm for the Isobaric-Isothermal Ensemble with Ewald Summations for All Long Range Forces

Nosé-Hoover chains: the canonical ensemble via continuous dynamics

Constant pressure molecular dynamics algorithms

A fully automated task-oriented interface for the analysis of molecular dynamics trajectories

Exact and efficient analytical calculation of the accessible surface areas and their gradients for macromolecules J

Investigating the local flexibility of functional residues in hemoproteins

Locating the active sites of enzymes using mechanical properties

BeAtMuSiC: Prediction of changes in protein-protein binding affinity on mutations

Perturbation-response scanning reveals ligand entry-exit mechanisms of ferric binding protein

Manipulation of conformational change in proteins by single-residue perturbations

Perturb-Scan-Pull: A Novel Method Facilitating Conformational Transitions in Proteins

ATPase subdomain IA is a mediator of interdomain allostery in Hsp70 molecular chaperones

Cooperative Dynamics of Intact AMPA and NMDA Glutamate Receptors: Similarities and Subfamily-Specific Differences

Dissecting Structure-Encoded Determinants of

Allosteric Cross-Talk between Post-Translational Modification Sites in the Hsp90 Chaperones

Dynamic Network Modeling of Allosteric Interactions and Communication Pathways in the SARS-CoV-2 Spike Trimer Mutants: Differential Modulation of Conformational Landscapes and Signal Transmission via Cascades of Regulatory Switches

A thermostable, closed SARS-CoV-2 spike protein trimer

Adaptability of protein structures to enable functional interactions and evolutionary implications

Intrinsic dynamics is evolutionarily optimized to enable allosteric behavior

Interaction analyses of SARS-CoV-2 spike protein based on fragment molecular orbital calculations RSC Adv

Molecular recognition of SARS-CoV-2 spike glycoprotein: quantum chemical hot spot and epitope analyses

Antibody resistance of SARS-CoV-2 variants B.1.351 and B.1.1.7

Functional plasticity and evolutionary adaptation of allosteric regulation